CannabisNewsBreaks Archive - Page 159 of 429

ThursdayApr 23, 2020 10:10 am

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Announces Notice of Allowance for New Patent, Issuance of Stock Options Under Equity Incentive Plan

Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP), a global innovator in drug delivery platforms, today announced its receipt of a Notice of Allowance from the United States Patent and Trademark Office ("USPTO") for a new patent. According to the update, the new patent provides additional claims that protect the use of its DehydraTECH(TM) technology together with cannabinoids, nicotine, nonsteroidal anti-inflammatory drugs, or vitamins in mix and serve beverage formats. This patent, with application number 16/497,920 under the title "Food and Beverage Compositions Infused With Lipophilic Active Agents and Methods of Use Thereof," signifies another addition to Lexaria's first patent family, under…

WednesdayApr 22, 2020 11:59 am

CannabisNewsBreaks – The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF) Announces Private Placement, Date for Release of Q4 Earnings

The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF) on Tuesday announced a non-brokered private placement for gross proceeds of C$20,000,000, with, at the company’s discretion, the ability to upsize the amount to an aggregate gross proceeds of C$25,000,000. According to the update, the company expects to use the proceeds of the Offering for general working capital purposes. “Despite the challenging capital markets environment, we are extremely fortunate to announce this financing and to have continued support from management and insiders who have been instrumental in Flowr’s founding, strategic direction and financing since inception,” Flowr’s CEO Vinay Tolia stated in the news…

WednesdayApr 22, 2020 10:13 am

CannabisNewsBreaks – Cannabis Global, Inc. (MCTC) and Sugarmade, Inc.’s (SGMD) BudCars Enter License Agreement for Production of Super-Premium Edibles for the California Marketplace

Cannabis Global (OTC: MCTC), a cannabinoid and hemp extract science forward company developing infusion and delivery technologies, today announced the licensing of several patent-pending technologies to Sugarmade’s (OTCQB: SGMD) Sacramento-based BudCars Cannabis Delivery Service for use in cannabis edibles for the regulated California marketplace. Under the agreement, Cannabis Global will license its unique cannabinoid infusion technologies to BudCars for the production of super-premium, highly bioavailable cannabis edibles. “We have developed and have pending patents on several technologies that not only make the production of cannabis edibles less expensive but also improve product quality. While we are rolling out our own…

TuesdayApr 21, 2020 12:21 pm

CannabisNewsBreaks – Kanvas(TM) Announces Vapetelligence(TM) Lite and Vapetelligence(TM) Enterprise Platforms – Taking Brand Ownership and End User Experience to New High

Kanvas(TM), creator of innovative solutions designed to elevate the user experience for legal cannabis and cannabidiol (“CBD”) consumers, on Monday announced the availability of the Vapetelligence™ Lite and Vapetelligence™ Enterprise smart pod customization platforms. According to the update, the platforms offer cannabis and CBD brands web-based, on-demand thermal profile creation and pod programming. “Until now, there’s never been a solution from hardware makers for brands to own the customization experience through on-site programming and testing,” Kanvas CEO Andy Fathollahi stated in the news release. “The Vapetelligence(TM) Lite and Vapetelligence(TM) Enterprise platforms are an unprecedented partnership of software and hardware powered…

TuesdayApr 21, 2020 10:20 am

CannabisNewsBreaks – Cannabis Global, Inc. (MCTC) Announces New Line of Cannabinoid Beverage Infusion Technologies and Industry’s First THC-V Tea and Coffee Products

Cannabis Global (OTC: MCTC), a cannabinoid and hemp extract science forward company developing infusion and delivery technologies, today announced a new line of cannabinoid beverage infusion technologies and the industry's first Tetrahydrocannabivarin (“THC-V”) tea and coffee products. According to the update, the Company plans to begin marketing both the infusion technologies and the tea and coffee products beginning May 1, 2020. "We have completed our product development into combining THC-V and other rare cannabinoids into infusion substrates, which can then be easily added to virtually any beverage or into many foods,” Cannabis Global CEO Arman Tabatabaei said in the news…

TuesdayApr 21, 2020 9:46 am

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Files New Patent Application for DehydraTECH Technology in Delivery of Antiviral Drugs

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP), a global innovator in drug delivery platforms, today announced that it has filed an important new patent application in the United States describing the use of its DehydraTECH(TM) technology for the delivery of antiviral drugs. According to the update, the technology would potentially be used to improve treatment options for viral infectious diseases including COVID-19, MERS, SARS, influenza, herpes, hepatitis and AIDS. "Lexaria's proprietary drug delivery platform has already proven its effectiveness in the oral delivery of other lipophilic drugs such as nicotine, cannabinoids, and more, with multi-fold increases in both the rate…

MondayApr 20, 2020 1:12 pm

CannabisNewsBreaks – Genius One, Inc. Announces Findings in Evaluating Cannabis as Potential Treatment of COVID -19 Complications

Genius One announced today that, due to the recent COVID-19 (SARS-CoV-2) virus outbreak and the resulting worldwide pandemic, it determined to research and study potential treatment of life-threatening cases. “Because Genius is an avid member of the cannabis movement and industry, when we were looking at possible solutions, we naturally evaluated the cannabis plant along with various cannabinoids, including Delta-9 and CBDs,” Genius CEO Dyan Ferman stated in the news release. “Our study focused on one main question: How can cannabinoids help in treatment of the virus, as well as virus-related complications and effects?” About Genius One, Inc. Genius is…

MondayApr 20, 2020 9:42 am

CannabisNewsBreaks – Cannabis Global, Inc. (MCTC) Offers Hemp You Can Feel(TM) Discounts for 420 – Traditional Cannabis Culture Celebration Day

Cannabis Global (OTC: MCTC), a cannabinoid and hemp extract science forward company developing infusion and delivery technologies, today announced special online discount codes for purchases of Hemp You Can Feel(TM) Coffee on April 20 - the traditional cannabis culture celebration day. According to the update, purchases of all products using code ALLUNITED will yield 25% off all products at the www.HempYouCanFeel.com website. "This is a unique product line based on what we believe to be the most bioavailable infusion technologies in the marketplace,” Cannabis Global CEO Arman Tabatabaei stated in the news release. "The organic coffee is super-premium and sourced…

FridayApr 17, 2020 2:00 pm

CannabisNewsBreaks – Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Completes Landmark Shipment of Premium Medical Cannabis Products to Israel

Supreme Cannabis Company (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) recently completed a landmark shipment containing Supreme Cannabis’ premium medical cannabis product from Canada to Israel (http://cnw.fm/8kJWr). An article discussing the company reads, “Supreme Cannabis interim president and CEO Colin Moore reported that the transaction, which was made possible through a partnership with Breath of Life International (BOL Pharma), represents a new international revenue opportunity for Supreme Cannabis and ‘builds Truverra’s global medical brand in one of the most sophisticated medical cannabis markets in the world.’ . . .‘With the support of BOL Pharma, we navigated both Canada and Israel’s complex regulatory…

FridayApr 17, 2020 1:50 pm

CannabisNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTC: SHRMF) (FWB: 496) Secures DTC Eligibility

Champignon Brands (CSE: SHRM) (OTC: SHRMF) (FWB: 496), a human optimization sciences company focused on applying novel and natural treatment protocols to address a broad range of disorders and deficiencies with an emphasis on psychedelic medicine, today announced that its common shares are now fully eligible for electronic clearing and settlement through the Depository Trust Company (“DTC”). Champignon’s common shares will continue to trade under the ticker symbol “SHRMF” on the OTC Markets. “We are actively engaged in pursuing new avenues of distribution both in North America and internationally, in order to enhance the ability of larger audiences to participate…

News and publishing service for cannabis related companies

Contact us: 512.354.7000

CannabisNewsBreaks